Call Us: 888-488-2702

TPG completes $1.84 billion deal for Par Pharmaceutical

By on Sep 28, 2012 in News |

Affiliates of private investment firm TPG have completed their $1.84 billion acquisition of generic drugmaker Par Pharmaceutical.